|
Volumn 102, Issue 3, 2007, Pages 473-477
|
Treating Helicobacter pylori without endoscopy in patients with dyspepsia
a b c,d |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROTON PUMP INHIBITOR;
ANTIINFECTIVE AGENT;
BACTERIAL INFECTION;
CANCER RISK;
COST EFFECTIVENESS ANALYSIS;
DYSPEPSIA;
ESOPHAGITIS;
ESOPHAGUS CANCER;
GASTROINTESTINAL ENDOSCOPY;
HEALTH CARE COST;
HELICOBACTER PYLORI;
HUMAN;
OUTCOME ASSESSMENT;
PEPTIC ULCER;
PREVALENCE;
PRIORITY JOURNAL;
QUALITY OF LIFE;
REVIEW;
RISK REDUCTION;
STOMACH CANCER;
TREATMENT OUTCOME;
ARTICLE;
CANADA;
HELICOBACTER INFECTION;
ISOLATION AND PURIFICATION;
MICROBIOLOGY;
MIDDLE AGED;
PRACTICE GUIDELINE;
PROGNOSIS;
RISK FACTOR;
STOMACH TUMOR;
UNITED KINGDOM;
UNITED STATES;
ANTI-BACTERIAL AGENTS;
CANADA;
DYSPEPSIA;
ENDOSCOPY, GASTROINTESTINAL;
ENGLAND;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
MIDDLE AGED;
PRACTICE GUIDELINES;
PREVALENCE;
PROGNOSIS;
RISK FACTORS;
STOMACH NEOPLASMS;
UNITED STATES;
|
EID: 33847327395
PISSN: 00029270
EISSN: 15720241
Source Type: Journal
DOI: 10.1111/j.1572-0241.2007.01088_1.x Document Type: Review |
Times cited : (8)
|
References (0)
|